Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 127.91%4.77M | ---- | -86.20%-17.07M | ---- | -231.34%-9.17M | ---- | -61.01%6.98M | ---- | 136.29%17.9M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 26.32%-14K | ---- | -90.00%-19K | ---- | -233.33%-10K | ---- | 93.88%-3K | ---- | -308.33%-49K |
| Interest expense - adjustment | ---- | -3.59%1.61M | ---- | 110.71%1.67M | ---- | -6.48%794K | ---- | -35.19%849K | ---- | 76.79%1.31M |
| Impairment and provisions: | ---- | -67.89%2.9M | ---- | -37.28%9.02M | ---- | 4,424.21%14.39M | ---- | 59.00%318K | ---- | -71.43%200K |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --728K | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | 778.18%2.9M | ---- | 195.65%330K | ---- | 15.85%-345K | ---- | -305.00%-410K | ---- | -71.43%200K |
| -Impairment of goodwill | ---- | ---- | ---- | -40.99%8.69M | ---- | --14.73M | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | -848.89%-427K | ---- | 30.77%-45K | ---- | 98.10%-65K | ---- | -233.13%-3.43M | ---- | -23.16%2.58M |
| -Other fair value changes | ---- | -848.89%-427K | ---- | 30.77%-45K | ---- | 98.10%-65K | ---- | -233.13%-3.43M | ---- | -23.16%2.58M |
| Asset sale loss (gain): | ---- | --9.38M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | --9.38M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -2.61%10.24M | ---- | 3.43%10.51M | ---- | -9.56%10.17M | ---- | -16.81%11.24M | ---- | 40.70%13.51M |
| -Amortization of intangible assets | ---- | -23.77%170K | ---- | 259.68%223K | ---- | -1.59%62K | ---- | -58.55%63K | ---- | -5.00%152K |
| Special items | ---- | 112.42%144K | ---- | 19.06%-1.16M | ---- | ---1.43M | ---- | ---- | ---- | ---91K |
| Operating profit before the change of operating capital | ---- | 880.96%28.6M | ---- | -80.13%2.92M | ---- | -8.07%14.67M | ---- | -54.87%15.96M | ---- | 61.02%35.36M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -93.58%156K | ---- | 162.08%2.43M | ---- | -366.37%-3.91M | ---- | 7,831.58%1.47M | ---- | -100.88%-19K |
| Accounts receivable (increase)decrease | ---- | -411.85%-49.77M | ---- | -492.06%-9.72M | ---- | -84.60%2.48M | ---- | 501.00%16.1M | ---- | 77.08%-4.02M |
| Accounts payable increase (decrease) | ---- | 365.10%31.6M | ---- | 583.90%6.79M | ---- | -131.99%-1.4M | ---- | 300.96%4.39M | ---- | -204.30%-2.18M |
| Special items for working capital changes | ---- | -145.02%-8.16M | ---- | 72.12%-3.33M | ---- | -140.14%-11.95M | ---- | -166.73%-4.98M | ---- | 226.15%7.46M |
| Cash from business operations | ---- | 363.79%2.42M | ---- | -670.59%-917K | ---- | -100.36%-119K | ---- | -10.01%32.94M | ---- | 1,212.77%36.6M |
| Other taxs | ---- | -27.25%710K | ---- | 151.40%976K | ---- | 69.24%-1.9M | ---- | -331.08%-6.17M | ---- | -351.74%-1.43M |
| Interest received - operating | ---- | -26.32%14K | ---- | 90.00%19K | ---- | 233.33%10K | ---- | -93.88%3K | ---- | 308.33%49K |
| Special items of business | 403.69%9.54M | ---- | 80.55%-3.14M | ---- | -165.05%-16.15M | ---- | -136.50%-6.09M | ---- | 22.56%16.7M | ---- |
| Net cash from operations | 403.69%9.54M | 3,929.49%3.14M | 80.55%-3.14M | 103.88%78K | -165.05%-16.15M | -107.50%-2.01M | -136.50%-6.09M | -23.99%26.77M | 22.56%16.7M | 1,318.32%35.22M |
| Cash flow from investment activities | ||||||||||
| Sale of fixed assets | ---- | ---- | ---- | --6K | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | ---- | 64.71%-54K | ---- | 70.69%-153K | ---- | 6.28%-522K | ---- | -26.02%-557K | ---- | 21.21%-442K |
| Purchase of intangible assets | ---- | ---- | ---- | ---847K | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---281K | ---- | ---- | ---- | 42.86%-7.05M | ---- | -252.54%-12.34M |
| Cash on investment | ---- | ---675K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | -191.13%-2.04M | ---2.17M | 86.24%-699K | ---- | -6,498.70%-5.08M | ---- | 82.89%-77K | ---- | -625.81%-450K | ---- |
| Net cash from investment operations | -191.13%-2.04M | -127.22%-2.9M | 86.24%-699K | -144.25%-1.28M | -6,498.70%-5.08M | 93.14%-522K | 82.89%-77K | 40.48%-7.61M | -625.81%-450K | -195.11%-12.78M |
| Net cash before financing | 295.44%7.51M | 120.55%246K | 81.91%-3.84M | 52.69%-1.2M | -244.08%-21.23M | -113.20%-2.53M | -137.98%-6.17M | -14.60%19.16M | 19.80%16.25M | 1,314.07%22.44M |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -47.08%27.25M | ---- | 64.43%51.5M | ---- | 46.58%31.32M | ---- | -45.50%21.37M | ---- | 165.64%39.21M |
| Refund | ---- | 25.59%-28.05M | ---- | -20.23%-37.69M | ---- | -32.66%-31.35M | ---- | 34.64%-23.63M | ---- | -279.59%-36.16M |
| Interest paid - financing | ---- | 3.59%-1.61M | ---- | -110.71%-1.67M | ---- | 6.48%-794K | ---- | 35.19%-849K | ---- | -76.79%-1.31M |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---12.67M | ---- | ---- |
| Other items of the financing business | 26.25%-4.83M | ---- | -143.85%-6.55M | ---- | 13,008.77%14.94M | ---- | 100.58%114K | ---- | -472.39%-19.53M | ---- |
| Net cash from financing operations | 26.25%-4.83M | -385.60%-11.36M | -143.85%-6.55M | 138.91%3.98M | 13,008.77%14.94M | 60.40%-10.23M | 100.58%114K | -155.22%-25.82M | -472.39%-19.53M | -142.36%-10.12M |
| Effect of rate | ---- | -63.77%-113K | ---- | -240.82%-69K | ---- | 116.44%49K | ---- | -734.04%-298K | ---- | --47K |
| Net Cash | 125.73%2.67M | -499.64%-11.12M | -65.27%-10.39M | 121.81%2.78M | -3.83%-6.29M | -91.60%-12.76M | -84.44%-6.06M | -154.03%-6.66M | -132.36%-3.28M | 304.58%12.32M |
| Begining period cash | -92.12%961K | 28.62%12.19M | 28.62%12.19M | -57.27%9.48M | -57.27%9.48M | -23.87%22.19M | -23.87%22.19M | 73.73%29.14M | 73.73%29.14M | -26.42%16.77M |
| Cash at the end | 102.17%3.64M | -92.12%961K | -43.64%1.8M | 28.62%12.19M | -80.22%3.19M | -57.27%9.48M | -37.62%16.13M | -23.87%22.19M | -3.96%25.86M | 73.73%29.14M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.